Table 1.
Spinal cord-injured patient information
| PT No. | Sex | Age | SCI Level | DOI | Duration, yr | Preop Capacity, ml | Preoperative Bladder Meds | Med Duration, mo |
|---|---|---|---|---|---|---|---|---|
| 1 | F | 20 | C5 | 1990/08/05 | 6.67 | 133 | Oxy, 5 mg BID | 60 |
| 2 | F | 17 | C5R, C7L | 1994/12/31 | 2.58 | 95 | Oxy, 5 mg TID | 8 |
| 3 | F | 22 | L1 spina bifida | NA | 22.00 | 63 | Oxy, 5 mg TID; Hyos, 0.375 mg BID; Dox, 8 mg QID | 6 |
| 4 | F | 18 | C4–5 | 1996/12/26 | 1.50 | 233 | Oxy, 5 mg QID; Imip, 10 mg TID | 13 |
| 5 | F | 18 | C6 | 1996/07/12 | 2.33 | 350 | Tol, 2 mg BID; Hyos, 0.375 mg BID | >1 |
| 6 | F | 18 | C7 | 1997/07/02 | 2.00 | 180 | Oxy-XL, 20 mg QD; Prob, 15 mg TID; Prob, 30 mg QHS | 7 |
| 7 | M | 17 | C5 | 1999/04/05 | 1.50 | 360 | Oxy-XL, 15 mg QD | 12 |
PT, patient; SCI, spinal cord injury; DOI, date of injury; NA, not available; BID, twice per day; QD, once per day; TID, three times per day; QID, taken four times per day; QHS, taken at bedtime; Oxy, oxybutynin; Oxy-XL, oxybutynin extended release (M3-selective antimuscarinic); Tol, tolterodine (nonselective antimuscarinic); Hyos, hyoscyamine (nonselective antimuscarinic); Imip, imipramine (tricyclic antidepressant that inhibits reuptake of serotonin and norepinephrine and that has some antimuscarinic effects); Prob, propantheline (non-subtype-selective antimuscarinic); Dox, doxazosin (a nonspecific α-1 antagonist); M, male; F, female; Preop, preoperative; Med, medication.